Tara Mitchell
Conference Co-Chair · University of Pennsylvania Health System
Credentials: · · · ·
History
- Present
Tara Miller Melanoma Center · University of Pennsylvania Health System
- 2007–2009
Research
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
New England Journal of Medicine · 2013 · 2,799 citations
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Nature · 2018 · 2,334 citations
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Nature · 2015 · 2,020 citations
59 papers
54 papers
52 papers
44 papers
34 papers · 27 as a fellow
19 papers
15 papers · 15 as a resident
14 papers
Clinical trials
- 2018–2027
Principal investigator · Active not recruiting · Phase 2
Abramson Cancer Center at Penn Medicine